Company · CIK 0000799231 · SIC 8300 — Services-Social Services
ALMOST FAMILY INC · AFAM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2015 SForm 4 → | Mar 3, 5:12 pm EST | William B YarmuthCEO, Director | 5,000 | $36.62 | $183,100 | 373,105 | −1.32% | plan? |
| Mar 2, 2015 AForm 4 → | Mar 3, 3:44 pm EST | P Todd LylesSr. Vice President Admin. | 4,200 | — | — | 85,550 | — | plan? |
| Feb 27, 2015 AFForm 4 → | Mar 3, 5:44 pm EST | Jeff ReibelVP & CAO | 2,332 | $33.20 | $17,662 | 6,859 | — | plan? |
| Feb 27, 2015 AFForm 4 → | Mar 3, 5:13 pm EST | C Steven GuenthnerPresident & PFO | 9,749 | $33.20 | $38,147 | 145,488 | — | plan? |
| Feb 27, 2015 SForm 4 → | Mar 3, 5:13 pm EST | C Steven GuenthnerPresident & PFO | 20,000 | $35.43 | $708,588 | 136,888 | −12.7% | plan? |
| Feb 27, 2015 AFForm 4 → | Mar 3, 5:13 pm EST | Raj KaushalSVP & Chief Clinical Officer | 3,341 | $33.20 | $27,921 | 8,459 | — | plan? |
| Feb 27, 2015 AFForm 4 → | Mar 3, 5:12 pm EST | William B YarmuthCEO, Director | 17,981 | $33.20 | $102,289 | 388,005 | — | plan? |
| Jan 22, 2015 PForm 4 → | Jan 23, 5:40 pm EST | NORTH TIDE CAPITAL, LLC +210% Owner | 19,500 | $31.49 | $613,961 | 1,250,000 | +1.58% | plan? |
| Jan 20, 2015 PForm 4 → | Jan 22, 5:11 pm EST | NORTH TIDE CAPITAL, LLC +210% Owner | 21,300 | $31.11 | $662,611 | 1,230,500 | +1.76% | plan? |
| Jan 14, 2015 PForm 4 → | Jan 16, 5:00 pm EST | NORTH TIDE CAPITAL, LLC +210% Owner | 7,000 | $30.14 | $210,974 | 1,209,200 | +0.58% | plan? |
| Jan 12, 2015 PForm 4 → | Jan 14, 5:02 pm EST | NORTH TIDE CAPITAL, LLC +210% Owner | 14,400 | $29.91 | $430,698 | 1,202,200 | +1.21% | plan? |
| Jan 8, 2015 PForm 4 → | Jan 12, 6:41 pm EST | NORTH TIDE CAPITAL, LLC +210% Owner | 97,300 | $29.21 | $2,841,833 | 1,187,800 | +8.92% | plan? |
| Dec 24, 2014 GForm 5 → | Jan 29, 2015, 1:47 pm EST | P Todd LylesSr. Vice President Admin. | 525 | — | — | 81,350 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2018 DForm 4 → | Apr 3, 6:57 pm EDT | Henry M Altman Jr.Director | 3,000 | — | — | 0 | — | |
| Apr 1, 2018 DForm 4 → | Apr 3, 6:48 pm EDT | John ShermyenSVP Healthcare Innovations | 1,900 | — | — | 0 | — | |
| Apr 1, 2018 DForm 4 → | Apr 3, 6:47 pm EDT | Sandra G HogstonSVP Hospital JV Operations | 1,500 | — | — | 0 | — | |
| Apr 1, 2018 DForm 4 → | Apr 3, 6:46 pm EDT | Daniel SchwartzSVP & COO | 29,100 | — | — | 0 | — | |
| Apr 1, 2018 DForm 4 → | Apr 3, 6:45 pm EDT | P Todd LylesSr. Vice President Admin. | 43,400 | — | — | 0 | — | |
| Apr 1, 2018 DForm 4 → | Apr 3, 6:45 pm EDT | Jeff ReibelVP Finance & CAO | 18,100 | — | — | 0 | — | |
| Apr 1, 2018 DForm 4 → | Apr 3, 6:44 pm EDT | C Steven GuenthnerPresident & PFO | 80,300 | — | — | 0 | — | |
| Apr 1, 2018 DForm 4 → | Apr 3, 6:43 pm EDT | William B YarmuthCEO, Director | 57,350 | — | — | 0 | — | |
| Apr 1, 2018 DForm 4 → | Apr 3, 6:41 pm EDT | Tyree G WilburnDirector | 3,000 | — | — | 0 | — | |
| Apr 1, 2018 DForm 4 → | Apr 3, 6:40 pm EDT | W Earl Reed IIIDirector | 3,000 | — | — | 0 | — | |
| Apr 1, 2018 DForm 4 → | Apr 3, 6:38 pm EDT | Jonathan GoldbergDirector | 3,000 | — | — | 0 | — | |
| Feb 28, 2018 MForm 4 → | Mar 2, 4:11 pm EST | C Steven GuenthnerPresident & PFO | 7,500 | — | — | 0 | — | |
| Dec 18, 2017 MForm 4 → | Dec 20, 9:49 am EST | Donald G McClintonDirector | 3,000 | — | — | 0 | — | |
| Dec 15, 2017 MForm 4 → | Dec 19, 10:16 am EST | William B YarmuthCEO, Director | 44,550 | $30.68 | $1,366,733 | 9,900 | — | |
| Dec 8, 2017 MForm 4 → | Dec 12, 6:43 pm EST | William B YarmuthCEO, Director | 55,200 | — | — | 0 | — | |
| May 12, 2017 MForm 4 → | May 16, 5:55 pm EDT | William B YarmuthCEO, Director | 20,000 | — | — | 0 | — | |
| Mar 10, 2017 AForm 4 → | Mar 14, 5:28 pm EDT | Raj KaushalSVP & Chief Clinical Officer | 1,400 | — | — | 1,400 | — | |
| Mar 10, 2017 AForm 4 → | Mar 14, 5:28 pm EDT | Jeff ReibelVP Finance & CAO | 1,500 | — | — | 1,500 | — | |
| Mar 10, 2017 AForm 4 → | Mar 14, 5:27 pm EDT | William B YarmuthCEO, Director | 16,100 | — | — | 16,100 | — | |
| Mar 10, 2017 AForm 4 → | Mar 14, 5:27 pm EDT | Daniel SchwartzSVP & COO | 4,300 | — | — | 4,300 | — | |
| Mar 10, 2017 AForm 4 → | Mar 14, 5:26 pm EDT | C Steven GuenthnerPresident & PFO | 9,400 | — | — | 9,400 | — | |
| Mar 10, 2017 AForm 4 → | Mar 14, 5:26 pm EDT | P Todd LylesSr. Vice President Admin. | 4,100 | — | — | 4,100 | — | |
| Mar 10, 2017 AForm 4 → | Mar 14, 5:26 pm EDT | John ShermyenSVP Healthcare Innovations | 800 | — | — | 800 | — | |
| Feb 1, 2017 MForm 4 → | Feb 3, 9:02 am EST | Tyree G WilburnDirector | 4,500 | — | — | 0 | — | |
| Feb 1, 2017 MForm 4 → | Feb 2, 3:39 pm EST | C Steven GuenthnerPresident & PFO | 15,000 | — | — | 0 | — | |
| Feb 1, 2017 MForm 4 → | Feb 2, 9:30 am EST | Jonathan GoldbergDirector | 4,500 | — | — | 0 | — | |
| Jan 18, 2017 MForm 4 → | Jan 20, 4:53 pm EST | Henry M Altman Jr.Director | 4,500 | — | — | 0 | — | |
| Jan 10, 2017 MForm 4 → | Jan 12, 8:41 am EST | Donald G McClintonDirector | 4,500 | — | — | 0 | — | |
| Jan 9, 2017 MForm 4 → | Jan 11, 4:47 pm EST | W Earl Reed IIIDirector | 1,125 | — | — | 0 | — | |
| Jan 5, 2017 MForm 4 → | Jan 9, 3:57 pm EST | William B YarmuthCEO, Director | 30,000 | — | — | 0 | — | |
| Dec 29, 2016 MForm 4 → | Dec 29, 4:49 pm EST | P Todd LylesSr. Vice President Admin. | 14,000 | — | — | 0 | — | |
| Mar 4, 2016 AForm 4 → | Mar 8, 6:15 pm EST | William B YarmuthCEO, Director | 21,400 | — | — | 21,400 | — | |
| Mar 4, 2016 AForm 4 → | Mar 8, 6:15 pm EST | C Steven GuenthnerPresident & PFO | 12,200 | — | — | 12,200 | — | |
| Mar 4, 2016 AForm 4 → | Mar 8, 6:14 pm EST | Jeff ReibelVP Finance & CAO | 2,000 | — | — | 2,000 | — | |
| Mar 4, 2016 AForm 4 → | Mar 8, 6:13 pm EST | Raj KaushalSVP & Chief Clinical Officer | 2,700 | — | — | 2,700 | — | |
| Mar 4, 2016 AForm 4 → | Mar 8, 6:13 pm EST | Daniel SchwartzSVP & COO | 5,700 | — | — | 5,700 | — | |
| Mar 4, 2016 AForm 4 → | Mar 8, 6:12 pm EST | P Todd LylesSr. Vice President Admin. | 4,900 | — | — | 4,900 | — | |
| Aug 5, 2015 MForm 4 → | Aug 5, 5:28 pm EDT | Steven B BingDirector | 3,000 | — | — | 0 | — | |
| Mar 2, 2015 AForm 4 → | Mar 3, 5:44 pm EST | Jeff ReibelVP & CAO | 2,400 | — | — | 2,400 | — | |
| Mar 2, 2015 AForm 4 → | Mar 3, 5:36 pm EST | Daniel SchwartzSVP & COO | 4,900 | — | — | 4,900 | — | |
| Mar 2, 2015 AForm 4 → | Mar 3, 5:13 pm EST | C Steven GuenthnerPresident & PFO | 11,500 | — | — | 11,500 | — | |
| Mar 2, 2015 AForm 4 → | Mar 3, 5:13 pm EST | Raj KaushalSVP & Chief Clinical Officer | 3,400 | — | — | 3,400 | — | |
| Mar 2, 2015 AForm 4 → | Mar 3, 5:12 pm EST | William B YarmuthCEO, Director | 19,800 | — | — | 19,800 | — | |
| Mar 2, 2015 AForm 4 → | Mar 3, 3:44 pm EST | P Todd LylesSr. Vice President Admin. | 5,600 | — | — | 5,600 | — |